[HTML][HTML] Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD
Background The administration of inhaled prostanoids to patients with pulmonary
hypertension (PH) related to idiopathic pulmonary fibrosis (IPF) and other fibrotic lung …
hypertension (PH) related to idiopathic pulmonary fibrosis (IPF) and other fibrotic lung …
Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in the French …
C Jambon-Barbara, A Hlavaty… - ERJ Open …, 2024 - Eur Respiratory Soc
Introduction Pulmonary arterial hypertension (PAH) is a rare and severe disease for which
most of the evidence about prognostic factors, evolution and treatment efficacy comes from …
most of the evidence about prognostic factors, evolution and treatment efficacy comes from …
Taking it to heart: dissecting cardiopulmonary interactions in diseases of the lung and the cardiovascular system
T Lahm - American Journal of Physiology-Lung Cellular and …, 2020 - journals.physiology.org
World Heart Day, celebrated annually on September 29, was established by the World Heart
Federation to generate awareness of cardiovascular disease (CVD)(7). CVD truly is a global …
Federation to generate awareness of cardiovascular disease (CVD)(7). CVD truly is a global …
Pulmonary arterial hypertension in the elderly: Clinical perspectives
N Rothbard, A Agrawal, C Fischer… - Cardiology …, 2020 - journals.viamedica.pl
Pulmonary hypertension (PH) is a rare and devastating disease characterized by
progressive increases in pulmonary arterial pressure and pulmonary vascular resistance …
progressive increases in pulmonary arterial pressure and pulmonary vascular resistance …
Hispanic ethnicity and social determinants of health: Harnessing data from the pulmonary hypertension association registry
RJ Bernardo… - Advances in Pulmonary …, 2022 - meridian.allenpress.com
Pulmonary arterial hypertension (PAH) is a chronic, progressive, and debilitating disease
associated with increased cardiopulmonary morbidity and mortality. Current knowledge is …
associated with increased cardiopulmonary morbidity and mortality. Current knowledge is …
Association between pulmonary hypertension and clinical outcomes in hospitalized patients with sickle cell disease
Methods The US National Inpatient Sample (NIS) database, which is part of the Healthcare
Cost and Utilization Project, contains deidentified data on patient demographics, insurance …
Cost and Utilization Project, contains deidentified data on patient demographics, insurance …
[HTML][HTML] The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension
Y Khatab, SR Ghafouri, H Alkhateeb… - Cardiology …, 2022 - ncbi.nlm.nih.gov
Background Measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) level is
an important parameter in the risk assessment of patients with pulmonary arterial …
an important parameter in the risk assessment of patients with pulmonary arterial …
Pulmonary arterial hypertension
B Leeper, B Powell - Nursing2020 Critical Care, 2019 - journals.lww.com
Pulmonary arterial hypertension is a rare and progressive disease associated with high
pulmonary vascular pressures leading to right ventricular failure and death. The exact …
pulmonary vascular pressures leading to right ventricular failure and death. The exact …
Impact of patient characteristics and perceived barriers on referral to exercise rehabilitation among patients with pulmonary hypertension in the United States
TM Cascino, C Ashur, CR Richardson… - Pulmonary …, 2020 - journals.sagepub.com
Exercise rehabilitation is underutilized in patients with pulmonary arterial hypertension
despite improving exercise capacity and quality of life. We sought to understand the …
despite improving exercise capacity and quality of life. We sought to understand the …
Pulmonary Hypertension: Transition Challenges in the Current Therapeutic Era
JD Awerbach, WJ Franklin - Transitioning Care from Pediatric to Adult …, 2021 - Springer
The management of pulmonary hypertension has evolved significantly over the past 30
years. The introduction of targeted pulmonary arterial hypertension pharmacotherapies …
years. The introduction of targeted pulmonary arterial hypertension pharmacotherapies …